# An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome

> **NCT00263068** · PHASE3 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 279 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Rotigotine

## Key facts

- **NCT ID:** NCT00263068
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 279 (ACTUAL)
- **Last updated:** 2014-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00263068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00263068, "An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00263068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*